An Appreciable CAGR Of 11% Expected To Be Witnessed By CMO/CDMO Biotechnology Market From 2021-2031.

1
An Appreciable CAGR Of 11 Expected To Be
Witnessed By CMO/CDMO Biotechnology Market From
2021-2031
Report Id PMRREP32516 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
North America to remain dominant in the global
parenteral medical nutrition market

• Key Takeaways from Market Study
• Standalone services hold around 57 value share,
  globally, primarily due to growing cell-line
  development services by biopharmaceutical and
  biotechnology companies.
• Leading global CDMOs are focusing on expansion of
  their manufacturing capabilities with high
  flexibility and rapid operation. With the help of
  advanced single-use technologies, companies are
  able to cut batch manufacturing and cleaning time
  from 7 days to 1 day.
• In terms of product, monoclonal antibodies are
  leading the market and are expected to
  hold 47 market share over the forecast period.
  This is owing to significant success rate of
  development and approval of both, bio-specific
  and antibody fragments.
• The mammalian segment widely dominates
  at 80 share, owing to the capabilities to add
  human-like post-translational modifications to
  complex protein therapeutics.
• By company size, mid-size contract development
  manufacturers accounted for the largest share of
  global CDMO/CMO biotechnology manufacturing. This
  is mainly because most of small operation CMOs
  have capabilities to produce enough antibodies.

 Get Sample Copy of Report _at_ https//www.persisten
cemarketresearch.com/samples/32516
4
Market Segmentation
Access Full Report _at_ https//www.persistencemarket
research.com/checkout/32516
5
(No Transcript)